The Germantown firm has found ways to use AI tools to speed up development work and cut costs for clients, while its CEO ...
YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...